US20020183288A1
(en)
*
|
1995-04-03 |
2002-12-05 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
ES2158611T3
(es)
*
|
1996-12-20 |
2001-09-01 |
Alza Corp |
Composicion en gel inyectable con efecto retard y procedimiento para la preparacion de dicha composicion.
|
US6994851B1
(en)
|
1997-07-10 |
2006-02-07 |
Mannkind Corporation |
Method of inducing a CTL response
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
US6193991B1
(en)
|
1997-10-29 |
2001-02-27 |
Atul J. Shukla |
Biodegradable delivery systems of biologically active substances
|
US6733767B2
(en)
*
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
US7128927B1
(en)
*
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
CA2361424C
(en)
*
|
1999-02-08 |
2009-04-28 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US7258869B1
(en)
*
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
IT1308187B1
(it)
*
|
1999-02-16 |
2001-12-07 |
Formenti Farmaceutici Spa |
Composizioni farmaceutiche topiche a base di antiinfiammatori nonsteroidei.
|
US7018365B2
(en)
|
1999-05-21 |
2006-03-28 |
Micro Therapeutics, Inc. |
Threaded syringe with quick stop
|
EP1949890A3
(de)
|
1999-06-04 |
2011-05-18 |
ALZA Corporation |
Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür
|
JP2003501375A
(ja)
*
|
1999-06-04 |
2003-01-14 |
アルザ・コーポレーション |
移植可能なゲル組成物および製造方法
|
WO2001003666A2
(en)
*
|
1999-07-12 |
2001-01-18 |
Scimed Life Systems, Inc. |
Liquid based vaso-occlusive compositions
|
US6461631B1
(en)
*
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
FR2802923B1
(fr)
*
|
1999-12-28 |
2002-03-08 |
Roquette Freres |
Procede de preparation d'une composition d'ester d'acide lactique et son utilisation en tant que solvant
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
US20030211974A1
(en)
*
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
US6998137B2
(en)
*
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
WO2001079354A1
(fr)
*
|
2000-04-12 |
2001-10-25 |
Sanko Chemical Industry Co., Ltd. |
Composition antistatique
|
EP1274459B1
(de)
|
2000-04-19 |
2005-11-16 |
Genentech, Inc. |
Formulierungen mit verzögerter freisetzung enthaltend wachstumshormon
|
SG98393A1
(en)
|
2000-05-19 |
2003-09-19 |
Inst Materials Research & Eng |
Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
|
JP2004511431A
(ja)
*
|
2000-06-28 |
2004-04-15 |
アトゥル・ジェイ・シュクラ |
生物活性物質を含む生分解性ビヒクルおよび送達システム
|
US20060177416A1
(en)
*
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
US7666445B2
(en)
*
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
US20020106406A1
(en)
*
|
2000-12-08 |
2002-08-08 |
Mchugh Anthony J. |
Crystallizable/non-crystallizable polymer composites
|
US7088002B2
(en)
*
|
2000-12-18 |
2006-08-08 |
Intel Corporation |
Interconnect
|
ATE361057T1
(de)
|
2000-12-21 |
2007-05-15 |
Alrise Biosystems Gmbh |
Verfahren umfassend einen induzierten phasenübergang zur herstellung von hydrophobe wirkstoffe enthaltenden mikropartikeln
|
US20020114795A1
(en)
|
2000-12-22 |
2002-08-22 |
Thorne Kevin J. |
Composition and process for bone growth and repair
|
US6500408B2
(en)
|
2001-01-27 |
2002-12-31 |
Jc Technologies, Inc. |
Enamel-safe tooth bleach and method for use
|
CA2439120C
(en)
|
2001-02-23 |
2011-07-05 |
Genentech, Inc. |
Erodible polymers for injection
|
CA2439472A1
(en)
*
|
2001-02-27 |
2002-09-06 |
University Of Rochester |
Methods and compositions for modifying apolipoprotein b mrna editing
|
US20040185101A1
(en)
*
|
2001-03-27 |
2004-09-23 |
Macromed, Incorporated. |
Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
|
US6590059B2
(en)
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
US7318931B2
(en)
*
|
2001-06-21 |
2008-01-15 |
Genentech, Inc. |
Sustained release formulation
|
EP1408876A4
(de)
|
2001-06-22 |
2004-09-22 |
Durect Corp |
Koaxiale implantate nullter ordnung mit verlängerter freisetzung
|
US7342089B2
(en)
*
|
2001-07-11 |
2008-03-11 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment for cachexia
|
US7345144B2
(en)
*
|
2001-07-11 |
2008-03-18 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment of cachexia
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US7732451B2
(en)
*
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
US7655658B2
(en)
*
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
WO2003013571A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
US7456184B2
(en)
*
|
2003-05-01 |
2008-11-25 |
Palatin Technologies Inc. |
Melanocortin receptor-specific compounds
|
GB2404865B
(en)
*
|
2001-09-11 |
2005-09-28 |
Caretek Medical Ltd |
Novel drug delivery technology
|
GB0122318D0
(en)
*
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
ITMI20012060A1
(it)
*
|
2001-10-05 |
2003-04-05 |
Recordati Chem Pharm |
Nuovi eterocilcli n-acilati
|
MXPA04004664A
(es)
*
|
2001-11-14 |
2004-09-10 |
Alza Corp |
Composiciones de deposito inyectables.
|
NZ533435A
(en)
*
|
2001-11-14 |
2007-10-26 |
Alza Corp |
Injectable depot compositions and uses thereof
|
CA2467239A1
(en)
*
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Catheter injectable depot compositions and uses thereof
|
HUP0402135A3
(en)
*
|
2001-11-30 |
2008-04-28 |
Pfizer |
Controlled release implant forming polymeric compositions of bone growth promoting compounds and process for their preparation
|
DK1484054T3
(da)
*
|
2002-02-22 |
2012-11-26 |
Santen Pharmaceutical Co Ltd |
Lægemiddelafgivelsessystem til subkonjunktival indgivelse af fine korn
|
ES2207387B1
(es)
*
|
2002-02-28 |
2005-07-16 |
Consejo Sup. Investig. Cientificas |
Composicion quimica de igf-i para el tratamiento y prevencion de enfermedades neurodegenerativas.
|
US6960346B2
(en)
*
|
2002-05-09 |
2005-11-01 |
University Of Tennessee Research Foundation |
Vehicles for delivery of biologically active substances
|
US7432245B2
(en)
*
|
2002-06-07 |
2008-10-07 |
Abbott Laboratories Inc. |
Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
AR039729A1
(es)
*
|
2002-06-25 |
2005-03-09 |
Alza Corp |
Formulaciones de deposito de corta duracion
|
US20040001889A1
(en)
*
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
US7160551B2
(en)
*
|
2002-07-09 |
2007-01-09 |
The Board Of Trustees Of The University Of Illinois |
Injectable system for controlled drug delivery
|
JP4723244B2
(ja)
*
|
2002-07-19 |
2011-07-13 |
オメロス コーポレイション |
生分解性トリブロックコポリマー、その合成方法、ならびにそれから作製されるヒドロゲルおよび生体材料
|
IL166418A0
(en)
*
|
2002-07-31 |
2006-01-15 |
Alza Corp |
Injectable depot compositions and uses thereof
|
CA2494400A1
(en)
|
2002-07-31 |
2004-02-05 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
US20050287648A1
(en)
*
|
2002-08-05 |
2005-12-29 |
University Of Rochester |
Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
AU2003267763A1
(en)
*
|
2002-10-25 |
2004-05-13 |
Pfizer Products Inc. |
Depot formulations of arylheterocyclic active agents in the form of a suspension
|
EP1562626B1
(de)
*
|
2002-10-29 |
2007-11-28 |
ALZA Corporation |
Stabilisierte feste polypeptidpartikel
|
US6918561B2
(en)
*
|
2002-10-31 |
2005-07-19 |
Yon So Chong |
Shell assembly for winding tire cord strip or belt cord strip
|
MXPA05004927A
(es)
*
|
2002-11-06 |
2005-09-08 |
Alza Corp |
Formulaciones de deposito de liberacion controlada.
|
JP2004196787A
(ja)
*
|
2002-12-04 |
2004-07-15 |
Santen Pharmaceut Co Ltd |
結膜下デポによるドラッグデリバリーシステム
|
CN101336887A
(zh)
*
|
2002-12-04 |
2009-01-07 |
参天制药株式会社 |
结膜下给药用药物组合物
|
CA2507522C
(en)
|
2002-12-13 |
2015-02-24 |
Durect Corporation |
Oral drug delivery system
|
US7731947B2
(en)
*
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
BR0317421A
(pt)
*
|
2002-12-19 |
2005-11-08 |
Alza Corp |
Géis de fase única não-aquosa estável e formulações destes para liberação a partir de um dispositivo implantável
|
WO2004057959A2
(en)
|
2002-12-20 |
2004-07-15 |
Generipharm, Inc. |
Intracutaneous injection
|
ES2282529T3
(es)
*
|
2003-02-03 |
2007-10-16 |
Hans-Dietrich Dr.Techn. Polaschegg |
Composicion para la prevencion de una infeccion debida a un dispositi vo permanente.
|
US6878374B2
(en)
|
2003-02-25 |
2005-04-12 |
Nitto Denko Corporation |
Biodegradable polyacetals
|
EP1622540A4
(de)
*
|
2003-03-11 |
2009-12-30 |
Qlt Usa Inc |
Formulierungen für zellen-plan-abhängige krebsmittel
|
DE10314082A1
(de)
*
|
2003-03-28 |
2004-10-21 |
Mcs Micro Carrier Systems Gmbh |
Biodegradierbares injizierbares Implantat
|
AU2004227986A1
(en)
*
|
2003-03-31 |
2004-10-21 |
Alza Corporation |
Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
|
KR20060002922A
(ko)
*
|
2003-03-31 |
2006-01-09 |
알자 코포레이션 |
비수성 단일 상 비히클 및 이러한 비히클을 이용한 제형
|
JP2006521897A
(ja)
*
|
2003-03-31 |
2006-09-28 |
アルザ・コーポレーション |
内部圧力を放散する手段を備える浸透ポンプ
|
TW584939B
(en)
*
|
2003-04-23 |
2004-04-21 |
Nanya Technology Corp |
Method of forming bottle-shaped trench and the method for fabricating bottle-shaped trench capacitors
|
US7968548B2
(en)
|
2003-05-01 |
2011-06-28 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific piperazine compounds with diamine groups
|
US7727990B2
(en)
|
2003-05-01 |
2010-06-01 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific piperazine and keto-piperazine compounds
|
US7727991B2
(en)
|
2003-05-01 |
2010-06-01 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific single acyl piperazine compounds
|
MY146351A
(en)
*
|
2003-05-29 |
2012-08-15 |
Schering Plough Ltd |
Compositions for treating infection in cattle and swine
|
CN1822816A
(zh)
*
|
2003-05-30 |
2006-08-23 |
阿尔萨公司 |
可植入的弹性体储库组合物、其用途以及制备方法
|
US20070184084A1
(en)
*
|
2003-05-30 |
2007-08-09 |
Guohua Chen |
Implantable elastomeric caprolactone depot compositions and uses thereof
|
AR047552A1
(es)
|
2003-06-26 |
2006-01-25 |
Control Delivery Sys Inc |
Sistemas de suministro de farmacos de liberacion sostenida biodegradables
|
US20050048123A1
(en)
|
2003-06-26 |
2005-03-03 |
Control Delivery System, Inc. |
In situ gelling drug delivery system
|
US20060286173A1
(en)
*
|
2003-08-20 |
2006-12-21 |
Kazuhito Yamada |
Drug delivery system for sub-tenon s capsule adminstration of fine grains
|
US7048925B2
(en)
|
2003-08-28 |
2006-05-23 |
Nitto Denko Corporation |
Acid-sensitive polyacetals and methods
|
EP1670895A4
(de)
*
|
2003-09-03 |
2007-11-14 |
Univ Rochester |
Cytidin-deaminase-aktivatoren, desoxycytidin-deaminase-aktivatoren, vif-antagonisten sowie screening-verfahren für moleküle davon
|
DE602004026747D1
(de)
|
2003-09-29 |
2010-06-02 |
Nitto Denko Corp |
Biologisch abbaubare polyacetale für die in-vivo-abgabe von polynucleotiden
|
EP1677781A4
(de)
*
|
2003-10-29 |
2008-11-19 |
Idexx Lab Inc |
Salze von pharmakologisch wirksamen verbindungen
|
US20050118206A1
(en)
*
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
CN1889929B
(zh)
*
|
2003-11-14 |
2013-04-10 |
阿尔萨公司 |
药物递送媒介物中的赋形剂
|
US20050106214A1
(en)
*
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US20050281879A1
(en)
*
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
CA2553254C
(en)
*
|
2004-01-12 |
2013-12-17 |
The Trustees Of The University Of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
US8221778B2
(en)
*
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
AU2005207002B2
(en)
|
2004-01-21 |
2011-03-17 |
University Of Utah Research Foundation |
Mutant sodium channel Nav1.7 and methods related thereto
|
US7429391B2
(en)
*
|
2004-01-30 |
2008-09-30 |
Access Business Group International Llc |
Holistic composition and method for reducing skin pigmentation
|
US8048086B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
US8048101B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
US8052669B2
(en)
|
2004-02-25 |
2011-11-08 |
Femasys Inc. |
Methods and devices for delivery of compositions to conduits
|
US9238127B2
(en)
|
2004-02-25 |
2016-01-19 |
Femasys Inc. |
Methods and devices for delivering to conduit
|
US7709484B1
(en)
|
2004-04-19 |
2010-05-04 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US20080248465A1
(en)
*
|
2004-04-26 |
2008-10-09 |
Uab Research Foundation |
Polymorphisms in the Fcgr2b Promoter and Uses Thereof
|
WO2005115410A2
(en)
*
|
2004-05-06 |
2005-12-08 |
University Of Rochester |
Context dependent inhibitors of cytidine deaminases and uses thereof
|
NZ550926A
(en)
*
|
2004-05-17 |
2010-01-29 |
Ares Trading Sa |
Hydrogel interferon formulations
|
US20050266087A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
UA92146C2
(ru)
*
|
2004-06-01 |
2010-10-11 |
Эйрэс Трейдинг С.А. |
Стабилизированная жидкая композиция, которая содержит интерферон
|
US7858115B2
(en)
*
|
2004-06-24 |
2010-12-28 |
Idexx Laboratories |
Phospholipid gel compositions for drug delivery and methods of treating conditions using same
|
US7854943B2
(en)
*
|
2004-06-24 |
2010-12-21 |
Idexx Laboratories |
Phospholipid gel compositions for drug delivery and methods of treating conditions using same
|
GB0417401D0
(en)
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
LT2767292T
(lt)
|
2004-09-17 |
2016-12-12 |
Durect Corporation |
Palaikomosios vietinės anestezijos mišinys su saib
|
CA2581143C
(en)
*
|
2004-09-21 |
2015-03-31 |
Shandong Luye Pharmaceutical Co., Ltd. |
Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
|
EP3173072A1
(de)
*
|
2004-10-01 |
2017-05-31 |
Ramscor, Inc. |
Einfach implantierbare wirkstoffzusammensetzungen mit verzögerter freisetzung
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
US8541413B2
(en)
*
|
2004-10-01 |
2013-09-24 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
AR052155A1
(es)
*
|
2004-12-14 |
2007-03-07 |
Novartis Ag |
Compuestos organicos
|
GB0428151D0
(en)
|
2004-12-22 |
2005-01-26 |
Novartis Ag |
Organic compounds
|
US20060141040A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
CN100425233C
(zh)
*
|
2005-01-12 |
2008-10-15 |
复旦大学 |
一种鼻腔用尼莫地平凝胶剂
|
US20060216242A1
(en)
*
|
2005-02-03 |
2006-09-28 |
Rohloff Catherine M |
Suspending vehicles and pharmaceutical suspensions for drug dosage forms
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006084083A2
(en)
*
|
2005-02-03 |
2006-08-10 |
Duramed Pharmaceuticals, Inc. |
Devices for delivering agents to a vaginal tract
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
EP2361630A1
(de)
*
|
2005-02-03 |
2011-08-31 |
Intarcia Therapeutics, Inc |
Implantierbares Arzneimittelfreigabesystem Partikel und eine osmotische Pumpe enthaltend
|
US7959938B2
(en)
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
US7674452B2
(en)
|
2005-03-16 |
2010-03-09 |
Nitto Denko Corporation |
Polymer coating of cells
|
US20060253068A1
(en)
*
|
2005-04-20 |
2006-11-09 |
Van Bilsen Paul |
Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
|
US20070015689A1
(en)
*
|
2005-06-23 |
2007-01-18 |
Alza Corporation |
Complexation of metal ions with polypeptides
|
EP1741440A1
(de)
*
|
2005-07-08 |
2007-01-10 |
Mellitus S.L. |
Verwendung von BPI-proteine zur Behandlung von stoffwechselbedingten Erkrankungen und Herzkreislaufstörungen
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
EP1909774A2
(de)
*
|
2005-08-04 |
2008-04-16 |
Angiotech International Ag |
Blockc-polymerzusammensetzung und verwendungen davon
|
US20070048288A1
(en)
*
|
2005-08-30 |
2007-03-01 |
Lyu Suping |
Shear thinning polymer cell delivery compositions
|
WO2007038246A2
(en)
*
|
2005-09-22 |
2007-04-05 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
JP5192384B2
(ja)
|
2005-09-22 |
2013-05-08 |
メディバス エルエルシー |
ビス−(α−アミノ)−ジオール−ジエステル含有ポリ(エステルアミド)およびポリ(エステルウレタン)組成物および使用の方法
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
JP5153340B2
(ja)
*
|
2005-11-16 |
2013-02-27 |
学校法人東海大学 |
薬剤放出制御組成物および薬剤放出性医療器具
|
EP1962894A4
(de)
*
|
2005-12-07 |
2012-11-14 |
Medivas Llc |
Verfahren zum zusammensetzen einer polymer-zusammensetzung zur abgabe eines biologischen mittels
|
US20070142287A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Biomed Solutions, Llc |
Compositions And Methods For Treatment Of Cancer
|
US20070184087A1
(en)
|
2006-02-06 |
2007-08-09 |
Bioform Medical, Inc. |
Polysaccharide compositions for use in tissue augmentation
|
US8580746B2
(en)
*
|
2006-03-30 |
2013-11-12 |
Palatin Technologies, Inc. |
Amide linkage cyclic natriuretic peptide constructs
|
CA2647146A1
(en)
*
|
2006-03-30 |
2007-10-11 |
Palatin Technologies, Inc. |
Linear natriuretic peptide constructs
|
BRPI0709427A2
(pt)
*
|
2006-03-30 |
2011-07-12 |
Palatin Technologies Inc |
"construto cìclico, composição farmacêutica e uso de um composto
|
JP5445130B2
(ja)
*
|
2006-05-02 |
2014-03-19 |
メディバス エルエルシー |
眼の外部または内部への眼科用薬剤の送達法
|
EP2021141A4
(de)
*
|
2006-05-09 |
2013-07-03 |
Medivas Llc |
Biologisch abbaubare wasserlösliche polymere
|
CN101453982B
(zh)
|
2006-05-30 |
2011-05-04 |
精达制药公司 |
两件式内部通道渗透递送系统流动调节器
|
GB0613333D0
(en)
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
GB0613638D0
(en)
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
CN101500430B
(zh)
|
2006-08-07 |
2014-02-19 |
诺维信公司 |
用于动物饲料的酶团粒
|
US20080031998A1
(en)
*
|
2006-08-07 |
2008-02-07 |
Novozymes A/S |
Enzyme Granules for Animal Feed
|
ES2422864T3
(es)
|
2006-08-09 |
2013-09-16 |
Intarcia Therapeutics, Inc |
Sistemas de liberación osmótica y unidades de pistón
|
US20080038332A1
(en)
*
|
2006-08-10 |
2008-02-14 |
Cai Gu Huang |
Stable pharmaceutical formulation comprising atorvastatin calcium
|
US7834017B2
(en)
|
2006-08-11 |
2010-11-16 |
Palatin Technologies, Inc. |
Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
|
GB0620685D0
(en)
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
US8999317B2
(en)
|
2006-11-01 |
2015-04-07 |
University Of Rochester |
Methods and compositions related to the structure and function of APOBEC3G
|
US8337883B2
(en)
|
2006-11-03 |
2012-12-25 |
Durect Corporation |
Transdermal delivery systems
|
US7718616B2
(en)
|
2006-12-21 |
2010-05-18 |
Zimmer Orthobiologics, Inc. |
Bone growth particles and osteoinductive composition thereof
|
KR100825519B1
(ko)
*
|
2007-01-05 |
2008-04-25 |
주식회사 바이오폴리메드 |
키토산 기재 고분자 접합체 및 그 제조방법
|
RU2440097C2
(ru)
|
2007-04-23 |
2012-01-20 |
Интарсия Терапьютикс, Инк. |
Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
|
DK2167039T3
(en)
*
|
2007-05-18 |
2017-01-09 |
Durect Corp |
Improved depot formulations
|
MX337286B
(es)
|
2007-05-25 |
2016-02-22 |
Indivior Uk Ltd |
Formulaciones de transferencia sostenida de compuestos de risperidona.
|
US10092524B2
(en)
|
2008-06-11 |
2018-10-09 |
Edge Therapeutics, Inc. |
Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
|
US9364432B2
(en)
*
|
2007-06-11 |
2016-06-14 |
Edge Therapeutics, Inc. |
Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
|
WO2009015143A1
(en)
*
|
2007-07-24 |
2009-01-29 |
Medivas, Llc |
Biodegradable cationic polymer gene transfer compositions and methods of use
|
US8470360B2
(en)
*
|
2008-04-18 |
2013-06-25 |
Warsaw Orthopedic, Inc. |
Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
|
KR20100067684A
(ko)
*
|
2007-11-05 |
2010-06-21 |
보오슈 앤드 롬 인코포레이팃드 |
약물 전달을 위한 비히클로서의 수불혼화성 물질
|
WO2009060473A2
(en)
*
|
2007-11-06 |
2009-05-14 |
Panacea Biotec Limited |
Injectable compositions, processes and uses thereof
|
CA2705520C
(en)
*
|
2007-11-13 |
2016-06-28 |
Surmodics Pharmaceuticals, Inc. |
Viscous terpolymers as drug delivery platform
|
CA2706658A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition
|
WO2009080699A2
(en)
*
|
2007-12-20 |
2009-07-02 |
Merck Serono S.A. |
Peg-interferon-beta formulations
|
US20090181068A1
(en)
*
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
KR20100121484A
(ko)
*
|
2008-02-15 |
2010-11-17 |
본 테라퓨틱스 소시에테아노님 |
골관절 질환의 치료 또는 예방에 사용하기 위한 약학 조성물
|
BRPI0905369C8
(pt)
|
2008-02-15 |
2021-05-25 |
Bone Therapeutics |
composição farmacêutica, uso da composição farmacêutica e kit compartimentado
|
US8828354B2
(en)
|
2008-03-27 |
2014-09-09 |
Warsaw Orthopedic, Inc. |
Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
|
US8956636B2
(en)
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating postoperative pain comprosing ketorolac
|
US9132085B2
(en)
|
2008-04-18 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating post-operative pain using clonidine and bupivacaine
|
US20090264489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
|
US9125917B2
(en)
*
|
2008-04-18 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Fluocinolone formulations in a biodegradable polymer carrier
|
US8722079B2
(en)
|
2008-04-18 |
2014-05-13 |
Warsaw Orthopedic, Inc. |
Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
|
US20090264477A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc., An Indiana Corporation |
Beta adrenergic receptor agonists for treatment of pain and/or inflammation
|
US8524267B2
(en)
*
|
2008-04-18 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Dexamethasone formulations in a biodegradable material
|
US9132119B2
(en)
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
US8420114B2
(en)
|
2008-04-18 |
2013-04-16 |
Warsaw Orthopedic, Inc. |
Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
|
US20090263443A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedics, Inc. |
Methods for treating post-operative effects such as spasticity and shivering with clondine
|
US9072727B2
(en)
|
2008-04-18 |
2015-07-07 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of degenerative disc disease
|
US8846068B2
(en)
*
|
2008-04-18 |
2014-09-30 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising a local anesthetic
|
US9289409B2
(en)
*
|
2008-04-18 |
2016-03-22 |
Warsaw Orthopedic, Inc. |
Sulindac formulations in a biodegradable material
|
US8889173B2
(en)
*
|
2008-04-18 |
2014-11-18 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
|
US8557273B2
(en)
|
2008-04-18 |
2013-10-15 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
USRE48948E1
(en)
|
2008-04-18 |
2022-03-01 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
US8956641B2
(en)
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of inflammatory diseases
|
US8629172B2
(en)
|
2008-04-18 |
2014-01-14 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising clonidine
|
US20090264478A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Sulfasalazine formulations in a biodegradable polymer carrier
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
US20100015049A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
|
US20100016808A1
(en)
*
|
2008-07-17 |
2010-01-21 |
Bioform Medical, Inc. |
Thin-Walled Delivery System
|
US9492375B2
(en)
|
2008-07-23 |
2016-11-15 |
Warsaw Orthopedic, Inc. |
Foam carrier for bone grafting
|
CN102186484A
(zh)
*
|
2008-08-13 |
2011-09-14 |
梅迪沃什有限公司 |
Aabb-聚(酯肽)可生物降解聚合物及其使用方法
|
US10070888B2
(en)
|
2008-10-03 |
2018-09-11 |
Femasys, Inc. |
Methods and devices for sonographic imaging
|
US9554826B2
(en)
|
2008-10-03 |
2017-01-31 |
Femasys, Inc. |
Contrast agent injection system for sonographic imaging
|
NZ592113A
(en)
*
|
2008-10-15 |
2012-04-27 |
Intarcia Therapeutics Inc |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
US20100098746A1
(en)
*
|
2008-10-20 |
2010-04-22 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
|
US9161903B2
(en)
|
2008-10-31 |
2015-10-20 |
Warsaw Orthopedic, Inc. |
Flowable composition that hardens on delivery to a target tissue site beneath the skin
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
CA2780624A1
(en)
|
2008-11-11 |
2010-05-20 |
Signum Biosciences, Inc. |
Isoprenyl derivatives useful as agents to modulate inflammation
|
WO2010065801A1
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Amine substituted piperazine melanocortin receptor-specific compounds
|
WO2010065802A2
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Substituted pyrrolidine or imidazolidine melanocortin receptor-specific compounds
|
WO2010065799A2
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Amine substituted piperidine melanocortin receptor-specific compounds
|
US20100168807A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Burton Kevin W |
Bioactive terpolymer compositions and methods of making and using same
|
US8980317B2
(en)
|
2008-12-23 |
2015-03-17 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating infections comprising a local anesthetic
|
US9480643B2
(en)
|
2008-12-23 |
2016-11-01 |
Surmodics Pharmaceuticals, Inc. |
Implantable composites and implants comprising same
|
US9415197B2
(en)
*
|
2008-12-23 |
2016-08-16 |
Surmodics, Inc. |
Implantable suction cup composites and implants comprising same
|
US8951546B2
(en)
*
|
2008-12-23 |
2015-02-10 |
Surmodics Pharmaceuticals, Inc. |
Flexible implantable composites and implants comprising same
|
US8974808B2
(en)
|
2008-12-23 |
2015-03-10 |
Surmodics, Inc. |
Elastic implantable composites and implants comprising same
|
US20100226959A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Matrix that prolongs growth factor release
|
US20100228097A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Methods and compositions to diagnose pain
|
US20100239632A1
(en)
*
|
2009-03-23 |
2010-09-23 |
Warsaw Orthopedic, Inc. |
Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
|
JP5805632B2
(ja)
|
2009-06-08 |
2015-11-04 |
パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. |
メラノコルチン受容体に特異的なペプチド
|
US8617583B2
(en)
|
2009-07-17 |
2013-12-31 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
|
US8653029B2
(en)
|
2009-07-30 |
2014-02-18 |
Warsaw Orthopedic, Inc. |
Flowable paste and putty bone void filler
|
US8231891B2
(en)
|
2009-07-31 |
2012-07-31 |
Warsaw Orthopedic, Inc. |
Implantable drug depot for weight control
|
WO2011015958A2
(en)
|
2009-08-06 |
2011-02-10 |
Koninklijke Philips Electronics N.V. |
Oncology therapies employing radioactive seeds
|
EP3323423B1
(de)
*
|
2009-09-28 |
2020-06-17 |
Intarcia Therapeutics, Inc |
Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
|
US20110097375A1
(en)
|
2009-10-26 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Formulation for preventing or reducing bleeding at a surgical site
|
US20110097380A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Clonidine formulations having antimicrobial properties
|
US9504698B2
(en)
*
|
2009-10-29 |
2016-11-29 |
Warsaw Orthopedic, Inc. |
Flowable composition that sets to a substantially non-flowable state
|
US8597192B2
(en)
|
2009-10-30 |
2013-12-03 |
Warsaw Orthopedic, Inc. |
Ultrasonic devices and methods to diagnose pain generators
|
EP2498603B1
(de)
|
2009-11-12 |
2016-07-13 |
Signum Biosciences, Inc. |
Verwendung von antibakteriellen mitteln zur behandlung von epithelbedingten erkrankungen
|
US9993441B2
(en)
|
2009-12-30 |
2018-06-12 |
Surmodics, Inc. |
Controlled release matrix barrier structure for subcutaneous medical devices
|
US8475824B2
(en)
*
|
2010-01-26 |
2013-07-02 |
Warsaw Orthopedic, Inc. |
Resorbable matrix having elongated particles
|
US8758791B2
(en)
*
|
2010-01-26 |
2014-06-24 |
Warsaw Orthopedic, Inc. |
Highly compression resistant matrix with porous skeleton
|
US9125902B2
(en)
*
|
2010-01-28 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Methods for treating an intervertebral disc using local analgesics
|
US9050274B2
(en)
*
|
2010-01-28 |
2015-06-09 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents
|
US9486500B2
(en)
|
2010-01-28 |
2016-11-08 |
Warsaw Orthopedic, Inc. |
Osteoimplant and methods for making
|
US20110229457A1
(en)
*
|
2010-03-12 |
2011-09-22 |
Surmodics, Inc. |
Injectable drug delivery system
|
WO2011116238A2
(en)
*
|
2010-03-17 |
2011-09-22 |
The Board Of Trustees Of The Leland Stanford Junior University. |
Light-sensitive ion-passing molecules
|
US10335366B2
(en)
|
2010-05-31 |
2019-07-02 |
Laboratorios Farmacéuticos Rovi, S.A. |
Risperidone or paliperidone implant formulation
|
US10350159B2
(en)
|
2010-05-31 |
2019-07-16 |
Laboratories Farmacéuticos Rovi, S.A. |
Paliperidone implant formulation
|
US10285936B2
(en)
|
2010-05-31 |
2019-05-14 |
Laboratorios Farmacéuticos Rovi, S.A. |
Injectable composition with aromatase inhibitor
|
ES2589106T3
(es)
|
2010-05-31 |
2016-11-10 |
Laboratorios Farmaceuticos Rovi, S.A. |
Composición inyectable antipsicótica de liberación controlada
|
US10881605B2
(en)
|
2010-05-31 |
2021-01-05 |
Laboratorios Farmaceuticos Rovi, S.A. |
Methods for the preparation of injectable depot compositions
|
SI2394663T1
(sl)
|
2010-05-31 |
2022-02-28 |
Laboratorios Farmaceuticos Rovi, S.A. |
Sestave za injicirane biološko razgradljive vsadke in situ
|
US10463607B2
(en)
|
2010-05-31 |
2019-11-05 |
Laboratorios Farmaceutics Rofi S.A. |
Antipsychotic Injectable Depot Composition
|
WO2011161531A1
(en)
*
|
2010-06-24 |
2011-12-29 |
Torrent Pharmaceuticals Limited |
Pharmaceutical composition containing goserelin for in-situ implant
|
WO2012012460A1
(en)
|
2010-07-19 |
2012-01-26 |
Xeris Pharmaceuticals, Inc. |
Stable glucagon formulations for the treatment of hypoglycemia
|
US8246571B2
(en)
|
2010-08-24 |
2012-08-21 |
Warsaw Orthopedic, Inc. |
Drug storage and delivery device having a retaining member
|
EP2611868B1
(de)
|
2010-08-30 |
2020-01-08 |
Surmodics Pharmaceuticals, Inc. |
Biologisch abbaubare terpolymere und terpolymermischungen als haftkleber
|
US11291483B2
(en)
|
2010-10-20 |
2022-04-05 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants
|
US10525169B2
(en)
|
2010-10-20 |
2020-01-07 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11207109B2
(en)
|
2010-10-20 |
2021-12-28 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US10525168B2
(en)
|
2010-10-20 |
2020-01-07 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11484627B2
(en)
|
2010-10-20 |
2022-11-01 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US20120101593A1
(en)
|
2010-10-20 |
2012-04-26 |
BIOS2 Medical, Inc. |
Implantable polymer for bone and vascular lesions
|
US11058796B2
(en)
|
2010-10-20 |
2021-07-13 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US8740982B2
(en)
|
2010-10-26 |
2014-06-03 |
Kyphon Sarl |
Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
|
US8404268B2
(en)
|
2010-10-26 |
2013-03-26 |
Kyphon Sarl |
Locally targeted anti-fibrotic agents and methods of use
|
US9414930B2
(en)
|
2010-10-26 |
2016-08-16 |
Kyphon SÀRL |
Activatable devices containing a chemonucleolysis agent
|
CA2817584C
(en)
|
2010-11-15 |
2018-01-02 |
Zimmer Orthobiologics, Inc. |
Bone void fillers
|
WO2012075447A2
(en)
|
2010-12-03 |
2012-06-07 |
Warsaw Orthopedic, Inc. |
Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
|
WO2012075451A2
(en)
|
2010-12-03 |
2012-06-07 |
Warsaw Orthopedic, Inc. |
Clonidine and gaba compounds in a biodegradable polymer carrier
|
US9060978B2
(en)
|
2011-01-24 |
2015-06-23 |
Warsaw Orthopedic, Inc. |
Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist
|
US9717779B2
(en)
|
2011-01-31 |
2017-08-01 |
Warsaw Orthopedic, Inc. |
Implantable matrix having optimum ligand concentrations
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
CN105853348B
(zh)
|
2011-03-10 |
2019-08-30 |
Xeris药物公司 |
肠胃外注射用稳定溶液
|
US9592243B2
(en)
|
2011-04-25 |
2017-03-14 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an anabolic agent for treatment of an injury
|
US9511077B2
(en)
|
2011-04-25 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an anabolic agent for wound healing
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
CN103748139B
(zh)
|
2011-06-23 |
2016-08-17 |
帝斯曼知识产权资产管理有限公司 |
用于递送生物活性剂的包含生物可降解的聚酯酰胺共聚物的微米颗粒或纳米颗粒
|
US9132194B2
(en)
|
2011-07-12 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an adhesive sheet containing a drug depot
|
US9205241B2
(en)
|
2011-07-12 |
2015-12-08 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an adhesive material
|
EP2773331B1
(de)
|
2011-10-31 |
2016-02-10 |
Xeris Pharmaceuticals, Inc. |
Formulierungen zur behandlung von diabetes
|
KR20230104761A
(ko)
*
|
2012-01-23 |
2023-07-10 |
알러간, 인코포레이티드 |
고화 디포-형성 주사가능 약물 제형에 현탁된 서방형생분해성 또는 생체흡수성 미소구체 또는 미립자
|
WO2013130877A1
(en)
|
2012-02-29 |
2013-09-06 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, including the use of composite implants
|
US9534018B2
(en)
|
2012-03-13 |
2017-01-03 |
Tensive Controls Inc. |
Melanocortin analogs having enhanced activity and transport
|
US9511018B2
(en)
|
2012-04-05 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable matrix
|
US8735504B2
(en)
|
2012-05-02 |
2014-05-27 |
Warsaw Orthopedic, Inc. |
Methods for preparing polymers having low residual monomer content
|
US9125805B2
(en)
|
2012-06-27 |
2015-09-08 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of small molecule drugs
|
US8835601B2
(en)
*
|
2012-12-21 |
2014-09-16 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptide delivery systems
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
US9018162B2
(en)
|
2013-02-06 |
2015-04-28 |
Xeris Pharmaceuticals, Inc. |
Methods for rapidly treating severe hypoglycemia
|
EA033537B1
(ru)
|
2013-03-11 |
2019-10-31 |
Durect Corp |
Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
CN105120659A
(zh)
|
2013-03-15 |
2015-12-02 |
度瑞公司 |
用于降低溶解可变性的具有流变改性剂的组合物
|
MX352907B
(es)
|
2013-03-15 |
2017-12-13 |
Heron Therapeutics Inc |
Composiciones de un poliortoéster y un solvente aprótico.
|
EP3795635A1
(de)
|
2013-05-23 |
2021-03-24 |
206 ORTHO, Inc. |
Vorrichtung zur behandlung von knochenbrüchen und/oder zur stärkung und/oder vermehrung von knochen einschliesslich der bereitstellung und verwendung zusammengesetzter implantate
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
US9764122B2
(en)
|
2014-07-25 |
2017-09-19 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having an occluding member
|
WO2016022831A1
(en)
|
2014-08-06 |
2016-02-11 |
Xeris Pharmaceuticals, Inc. |
Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
|
WO2016044683A1
(en)
|
2014-09-19 |
2016-03-24 |
Tensive Controls, Inc. |
Anti-microbial peptides
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
EP3233067B1
(de)
|
2014-12-18 |
2019-11-06 |
DSM IP Assets B.V. |
Arzneimittelabgabesystem zur abgabe von säureempfindlichen arzneimitteln
|
EP3240585A1
(de)
*
|
2014-12-29 |
2017-11-08 |
Boston Scientific Scimed Inc. |
Zusammensetzungen, vorrichtungen und verfahren zur mehrstufigen freisetzung von chemotherapeutika
|
WO2016168388A2
(en)
|
2015-04-14 |
2016-10-20 |
Palatin Technologies, Inc. |
Therapies for obesity, diabetes and related indications
|
EP3302354B1
(de)
|
2015-06-03 |
2023-10-04 |
i2o Therapeutics, Inc. |
Systeme zum einsetzen eines implantats
|
US9649364B2
(en)
|
2015-09-25 |
2017-05-16 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic formulations in aprotic polar solvents
|
US11590205B2
(en)
|
2015-09-25 |
2023-02-28 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD802755S1
(en)
|
2016-06-23 |
2017-11-14 |
Warsaw Orthopedic, Inc. |
Drug pellet cartridge
|
CN109477044B
(zh)
|
2016-07-19 |
2021-10-08 |
艺康美国股份有限公司 |
用于去除口香糖和其它粘性食物的方法和清洁溶液
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
KR20190104039A
(ko)
|
2017-01-03 |
2019-09-05 |
인타르시아 세라퓨틱스 인코포레이티드 |
Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
|
KR20240036128A
(ko)
|
2017-06-02 |
2024-03-19 |
엑스에리스 파머수티클스, 인크. |
침전 방지 저분자 약물 제제
|
CN107595765A
(zh)
*
|
2017-09-22 |
2018-01-19 |
沈阳兴齐眼药股份有限公司 |
一种眼用缓释药物递送系统及其制备方法
|
US20210121428A1
(en)
*
|
2019-10-25 |
2021-04-29 |
Warsaw Orthopedic, Inc. |
Compositions for treatment of annular spinal disc injury
|
CA3167217A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
CN112516372A
(zh)
*
|
2020-11-12 |
2021-03-19 |
盐城工学院 |
一种用于可吸收手术缝合线的复合载药纤维
|
CA3231500A1
(en)
|
2021-09-09 |
2023-03-16 |
Xeris Pharmaceuticals, Inc. |
Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereof
|
WO2023046731A1
(en)
|
2021-09-21 |
2023-03-30 |
Laboratorios Farmacéuticos Rovi, S.A. |
Antipsychotic injectable extended-release composition
|